A 0 1 0 1 O
tumor 2 7 2 7 B-cancer
is 8 10 8 10 O
considered 11 21 11 21 O
unresectable 22 34 22 34 O
when 35 39 35 39 O
invading 40 48 40 48 O
adjacent 49 57 49 57 O
organs 58 64 58 64 O
and 65 68 65 68 O
an 69 71 69 71 O
en 72 74 72 74 O
block 75 80 75 80 O
resection 81 90 81 90 O
will 91 95 91 95 O
not 96 99 96 99 O
achieve 100 107 100 107 O
negative 108 116 108 116 O
margins 117 124 117 124 O

A 0 1 125 126 O
woman 2 7 127 132 B-gender
of 8 10 133 135 O
childbearing 11 23 136 148 O
potential 24 33 149 158 O
is 34 36 159 161 O
defined 37 44 162 169 O
of 45 47 170 172 O
one 48 51 173 176 O
who 52 55 177 180 O
is 56 58 181 183 O
biologically 59 71 184 196 O
capable 72 79 197 204 O
of 80 82 205 207 O
becoming 83 91 208 216 B-pregnancy
pregnant 92 100 217 225 I-pregnancy

ANC 0 3 226 229 B-clinical_variable
> 4 5 230 231 O
1.5 6 9 232 235 B-lower_bound
cells 10 15 236 241 I-lower_bound
/ 15 16 241 242 I-lower_bound
mm3 16 19 242 245 I-lower_bound
, 19 20 245 246 O
HGB 21 24 247 250 B-clinical_variable
> 25 26 251 252 O
8.0 27 30 253 256 B-lower_bound
gm 31 33 257 259 I-lower_bound
/ 33 34 259 260 I-lower_bound
dl 34 36 260 262 I-lower_bound
, 36 37 262 263 O
PLT 38 41 264 267 B-clinical_variable
> 42 43 268 269 O
150,000 44 51 270 277 B-lower_bound
/ 51 52 277 278 I-lower_bound
mm3 52 55 278 281 I-lower_bound
total 56 61 282 287 B-clinical_variable
bilirubin 62 71 288 297 I-clinical_variable
≤ 72 73 298 299 O
1.5 74 77 300 303 B-upper_bound
x 78 79 304 305 I-upper_bound
ULN 80 83 306 309 I-upper_bound
( 84 85 310 311 O
except 85 91 311 317 O
in 92 94 318 320 O
patients 95 103 321 329 O
with 104 108 330 334 O
Gilbert 109 116 335 342 B-chronic_disease
's 116 118 342 344 I-chronic_disease
Syndrome 119 127 345 353 I-chronic_disease
who 128 131 354 357 O
must 132 136 358 362 O
have 137 141 363 367 O
total 142 147 368 373 O
bilirubin 148 157 374 383 O
≤ 158 159 384 385 O
3.0 160 163 386 389 B-upper_bound
x 164 165 390 391 I-upper_bound
ULN 166 169 392 395 I-upper_bound
) 169 170 395 396 O
, 170 171 396 397 O
AST≤ 172 176 398 402 B-clinical_variable
3 177 178 403 404 B-upper_bound
x 179 180 405 406 I-upper_bound
ULN 181 184 407 410 I-upper_bound
, 184 185 410 411 O
ALT 186 189 412 415 B-clinical_variable
≤ 190 191 416 417 O
3 192 193 418 419 O
x 194 195 420 421 O
ULN 196 199 422 425 O

Age 0 3 426 429 B-age
≥ 4 5 430 431 O
18 6 8 432 434 B-lower_bound
years 9 14 435 440 I-lower_bound
The 15 18 441 444 O
minimum 19 26 445 452 O
legal 27 32 453 458 O
age 33 36 459 462 B-age
of 37 39 463 465 O
consent 40 47 466 473 O
for 48 51 474 477 O
select 52 58 478 484 O
Canadian 59 67 485 493 O
provinces 68 77 494 503 O
is 78 80 504 506 O
19 81 83 507 509 O

Clinical 0 8 510 518 O
Stage 9 14 519 524 O
II 15 17 525 527 O
( 18 19 528 529 O
T3 19 21 529 531 O
- 21 22 531 532 O
4 22 23 532 533 O
, 23 24 533 534 O
N- 25 27 535 537 O
) 27 28 537 538 O
or 29 31 539 541 O
Stage 32 37 542 547 O
III 38 41 548 551 O
( 42 43 552 553 O
any 43 46 553 556 O
T 47 48 557 558 O
, 48 49 558 559 O
N+ 50 52 560 562 O
) 52 53 562 563 O
based 54 59 564 569 O
on 60 62 570 572 O
MRI 63 66 573 576 B-treatment

Creatinine 0 10 577 587 B-clinical_variable
level 11 16 588 593 O
greater 17 24 594 601 O
than 25 29 602 606 O
1.5 30 33 607 610 B-lower_bound
times 34 39 611 616 I-lower_bound
the 40 43 617 620 I-lower_bound
upper 44 49 621 626 I-lower_bound
limit 50 55 627 632 I-lower_bound
of 56 58 633 635 I-lower_bound
normal 59 65 636 642 I-lower_bound

ECOG 0 4 643 647 B-clinical_variable
Performance 5 16 648 659 I-clinical_variable
status 17 23 660 666 I-clinical_variable
0 24 25 667 668 B-lower_bound
- 25 26 668 669 O
2 26 27 669 670 B-upper_bound

Histologically 0 14 671 685 O
confirmed 15 24 686 695 O
diagnosis 25 34 696 705 O
of 35 37 706 708 O
adenocarcinoma 38 52 709 723 B-cancer
of 53 55 724 726 O
the 56 59 727 730 O
rectum 60 66 731 737 O

No 0 2 738 740 O
active 3 9 741 747 B-chronic_disease
infections 10 20 748 758 I-chronic_disease
requiring 21 30 759 768 O
systemic 31 39 769 777 B-treatment
antibiotic 40 50 778 788 I-treatment
treatment 51 60 789 798 I-treatment
( 61 62 799 800 O
oral 62 66 800 804 B-treatment
antibiotics 67 78 805 816 I-treatment
are 79 82 817 820 O
acceptable 83 93 821 831 O
at 94 96 832 834 O
the 97 100 835 838 O
discretion 101 111 839 849 O
of 112 114 850 852 O
the 115 118 853 856 O
treating 119 127 857 865 O
physician 128 137 866 875 O
) 137 138 875 876 O

No 0 2 877 879 O
evidence 3 11 880 888 O
of 12 14 889 891 O
distant 15 22 892 899 O
metastases 23 33 900 910 B-cancer

No 0 2 911 913 O
other 3 8 914 919 O
experimental 9 21 920 932 B-treatment
therapies 22 31 933 942 I-treatment
( 32 33 943 944 O
including 33 42 944 953 O
chemotherapy 43 55 954 966 B-treatment
, 55 56 966 967 O
radiation 57 66 968 977 B-treatment
, 66 67 977 978 O
hormonal 68 76 979 987 B-treatment
treatment 77 86 988 997 I-treatment
, 86 87 997 998 O
antibody 88 96 999 1007 B-treatment
therapy 97 104 1008 1015 I-treatment
, 104 105 1015 1016 O
immunotherapy 106 119 1017 1030 B-treatment
, 119 120 1030 1031 O
gene 121 125 1032 1036 B-treatment
therapy 126 133 1037 1044 I-treatment
, 133 134 1044 1045 O
vaccine 135 142 1046 1053 B-treatment
therapy 143 150 1054 1061 I-treatment
, 150 151 1061 1062 O
angiogenesis 152 164 1063 1075 B-treatment
inhibitors 165 175 1076 1086 I-treatment
, 175 176 1086 1087 O
matrix 177 183 1088 1094 B-treatment
metalloprotease 184 199 1095 1110 I-treatment
inhibitors 200 210 1111 1121 I-treatment
, 210 211 1121 1122 O
thalidomide 212 223 1123 1134 B-treatment
, 223 224 1134 1135 O
anti 225 229 1136 1140 B-treatment
- 229 230 1140 1141 I-treatment
VEGF 230 234 1141 1145 I-treatment
/ 234 235 1145 1146 I-treatment
Flk-1 235 240 1146 1151 I-treatment
monoclonal 241 251 1152 1162 I-treatment
antibody 252 260 1163 1171 I-treatment
or 261 263 1172 1174 O
other 264 269 1175 1180 O
experimental 270 282 1181 1193 B-treatment
drugs 283 288 1194 1199 I-treatment
) 288 289 1199 1200 O
of 290 292 1201 1203 O
any 293 296 1204 1207 O
kind 297 301 1208 1212 O
are 302 305 1213 1216 O
permitted 306 315 1217 1226 O
while 316 321 1227 1232 O
the 322 325 1233 1236 O
patient 326 333 1237 1244 O
is 334 336 1245 1247 O
receiving 337 346 1248 1257 O
study 347 352 1258 1263 O
treatment 353 362 1264 1273 O

No 0 2 1274 1276 O
prior 3 8 1277 1282 O
chemotherapy 9 21 1283 1295 B-treatment
or 22 24 1296 1298 O
surgery 25 32 1299 1306 B-treatment
for 33 36 1307 1310 O
rectal 37 43 1311 1317 B-cancer
cancer 44 50 1318 1324 I-cancer

No 0 2 1325 1327 O
prior 3 8 1328 1333 B-treatment
pelvic 9 15 1334 1340 I-treatment
radiation 16 25 1341 1350 I-treatment
therapy 26 33 1351 1358 I-treatment

Other 0 5 1359 1364 O
Anticancer 6 16 1365 1375 B-treatment
or 17 19 1376 1378 O
Experimental 20 32 1379 1391 B-treatment
Therapy 33 40 1392 1399 I-treatment

Patients 0 8 1400 1408 O
who 9 12 1409 1412 O
are 13 16 1413 1416 O
unable 17 23 1417 1423 O
to 24 26 1424 1426 O
undergo 27 34 1427 1434 O
an 35 37 1435 1437 O
MRI 38 41 1438 1441 B-treatment

Patients 0 8 1442 1450 O
who 9 12 1451 1454 O
do 13 15 1455 1457 B-language_fluency
not 16 19 1458 1461 I-language_fluency
read 20 24 1462 1466 I-language_fluency
or 25 27 1467 1469 I-language_fluency
understand 28 38 1470 1480 I-language_fluency
English 39 46 1481 1488 I-language_fluency
are 47 50 1489 1492 O
eligible 51 59 1493 1501 O
and 60 63 1502 1505 O
may 64 67 1506 1509 O
be 68 70 1510 1512 O
consented 71 80 1513 1522 O
according 81 90 1523 1532 O
to 91 93 1533 1535 O
institutional 94 107 1536 1549 O
and 108 111 1550 1553 O
federal 112 119 1554 1561 O
regulations 120 131 1562 1573 O

Patients 0 8 1574 1582 O
who 9 12 1583 1586 O
have 13 17 1587 1591 O
received 18 26 1592 1600 O
prior 27 32 1601 1606 B-treatment
pelvic 33 39 1607 1613 I-treatment
radiotherapy 40 52 1614 1626 I-treatment

Patients 0 8 1627 1635 O
with 9 13 1636 1640 O
a 14 15 1641 1642 O
history 16 23 1643 1650 O
of 24 26 1651 1653 O
a 27 28 1654 1655 O
prior 29 34 1656 1661 O
malignancy 35 45 1662 1672 B-cancer
within 46 52 1673 1679 O
the 53 56 1680 1683 O
past 57 61 1684 1688 B-upper_bound
5 62 63 1689 1690 I-upper_bound
years 64 69 1691 1696 I-upper_bound

Patients 0 8 1697 1705 O
with 9 13 1706 1710 O
a 14 15 1711 1712 O
history 16 23 1713 1720 O
of 24 26 1721 1723 O
any 27 30 1724 1727 O
arterial 31 39 1728 1736 B-chronic_disease
thrombotic 40 50 1737 1747 I-chronic_disease
event 51 56 1748 1753 O
within 57 63 1754 1760 O
the 64 67 1761 1764 O
past 68 72 1765 1769 B-upper_bound
6 73 74 1770 1771 I-upper_bound
months 75 81 1772 1778 I-upper_bound

Patients 0 8 1779 1787 O
with 9 13 1788 1792 O
a 14 15 1793 1794 O
history 16 23 1795 1802 O
of 24 26 1803 1805 O
venous 27 33 1806 1812 O
thrombotic 34 44 1813 1823 O
episodes 45 53 1824 1832 O
such 54 58 1833 1837 O
as 59 61 1838 1840 O
deep 62 66 1841 1845 B-chronic_disease
venous 67 73 1846 1852 I-chronic_disease
thrombosis 74 84 1853 1863 I-chronic_disease
, 84 85 1863 1864 O
pulmonary 86 95 1865 1874 B-chronic_disease
embolus 96 103 1875 1882 I-chronic_disease
occurring 104 113 1883 1892 O

Patients 0 8 1893 1901 O
with 9 13 1902 1906 O
any 14 17 1907 1910 O
other 18 23 1911 1916 O
concurrent 24 34 1917 1927 O
medical 35 42 1928 1935 O
or 43 45 1936 1938 O
psychiatric 46 57 1939 1950 B-chronic_disease
condition 58 67 1951 1960 I-chronic_disease
or 68 70 1961 1963 O
disease 71 78 1964 1971 B-chronic_disease
which 79 84 1972 1977 O
, 84 85 1977 1978 O
in 86 88 1979 1981 O
the 89 92 1982 1985 O
investigator 93 105 1986 1998 O
's 105 107 1998 2000 O
judgment 108 116 2001 2009 O
, 116 117 2009 2010 O
would 118 123 2011 2016 O
make 124 128 2017 2021 O
them 129 133 2022 2026 O
inappropriate 134 147 2027 2040 O
candidates 148 158 2041 2051 O
for 159 162 2052 2055 O
entry 163 168 2056 2061 O
into 169 173 2062 2066 O
this 174 178 2067 2071 O
study 179 184 2072 2077 O

Primary 0 7 2078 2085 O
unresectable 8 20 2086 2098 O
rectal 21 27 2099 2105 B-cancer
cancer 28 34 2106 2112 I-cancer

Rectal 0 6 2113 2119 B-cancer
tumor 7 12 2120 2125 I-cancer
at 13 15 2126 2128 O
baseline 16 24 2129 2137 O
which 25 30 2138 2143 O
would 31 36 2144 2149 O
be 37 39 2150 2152 O
considered 40 50 2153 2163 O
to 51 53 2164 2166 O
require 54 61 2167 2174 O
complete 62 70 2175 2183 O
TME 71 74 2184 2187 O

Recurrent 0 9 2188 2197 B-cancer
rectal 10 16 2198 2204 I-cancer
cancer 17 23 2205 2211 I-cancer

This 0 4 2212 2216 O
includes 5 13 2217 2225 O
angina 14 20 2226 2232 B-chronic_disease
( 21 22 2233 2234 I-chronic_disease
stable 22 28 2234 2240 I-chronic_disease
or 29 31 2241 2243 I-chronic_disease
unstable 32 40 2244 2252 I-chronic_disease
) 40 41 2252 2253 I-chronic_disease
, 41 42 2253 2254 O
MI 43 45 2255 2257 B-chronic_disease
, 45 46 2257 2258 O
TIA 47 50 2259 2262 B-chronic_disease
, 50 51 2262 2263 O
or 52 54 2264 2266 O
CVA 55 58 2267 2270 B-chronic_disease

WOCBP 0 5 2271 2276 O
who 6 9 2277 2280 O
are 10 13 2281 2284 O
unwilling 14 23 2285 2294 O
or 24 26 2295 2297 O
unable 27 33 2298 2304 O
to 34 36 2305 2307 O
use 37 40 2308 2311 O
an 41 43 2312 2314 O
acceptable 44 54 2315 2325 O
method 55 61 2326 2332 O
of 62 64 2333 2335 O
avoiding 65 73 2336 2344 O
pregnancy 74 83 2345 2354 B-pregnancy
for 84 87 2355 2358 O
the 88 91 2359 2362 O
entire 92 98 2363 2369 O
study 99 104 2370 2375 O
period 105 111 2376 2382 O

Women 0 5 2383 2388 B-gender
who 6 9 2389 2392 O
are 10 13 2393 2396 B-pregnancy
pregnant 14 22 2397 2405 I-pregnancy

Women 0 5 2406 2411 B-gender
with 6 10 2412 2416 O
childbearing 11 23 2417 2429 O
potential 24 33 2430 2439 O
( 34 35 2440 2441 O
WOCBP 35 40 2441 2446 O
) 40 41 2446 2447 O
who 42 45 2448 2451 O
are 46 49 2452 2455 O
negative 50 58 2456 2464 B-pregnancy
for 59 62 2465 2468 I-pregnancy
pregnancy 63 72 2469 2478 I-pregnancy
test 73 77 2479 2483 O
( 78 79 2484 2485 O
urine 79 84 2485 2490 O
or 85 87 2491 2493 O
blood 88 93 2494 2499 O
) 93 94 2499 2500 O
and 95 98 2501 2504 O
who 99 102 2505 2508 O
agree 103 108 2509 2514 B-contraception_consent
to 109 111 2515 2517 I-contraception_consent
use 112 115 2518 2521 I-contraception_consent
effective 116 125 2522 2531 I-contraception_consent
contraceptive 126 139 2532 2545 I-contraception_consent
method 140 146 2546 2552 I-contraception_consent

except 0 6 2553 2559 O
for 7 10 2560 2563 O
adequately 11 21 2564 2574 O
treated 22 29 2575 2582 O
basal 30 35 2583 2588 B-cancer
cell 36 40 2589 2593 I-cancer
or 41 43 2594 2596 O
squamous 44 52 2597 2605 B-cancer
cell 53 57 2606 2610 I-cancer
skin 58 62 2611 2615 I-cancer
cancer 63 69 2616 2622 I-cancer
or 70 72 2623 2625 O
in 73 75 2626 2628 O
situ 76 80 2629 2633 O
cervical 81 89 2634 2642 B-cancer
cancer 90 96 2643 2649 I-cancer

more 0 4 2650 2654 O
than 5 9 2655 2659 O
6 10 11 2660 2661 B-lower_bound
months 12 18 2662 2668 I-lower_bound
prior 19 24 2669 2674 I-lower_bound
to 25 27 2675 2677 O
enrollment 28 38 2678 2688 O
may 39 42 2689 2692 O
be 43 45 2693 2695 O
considered 46 56 2696 2706 O
for 57 60 2707 2710 O
protocol 61 69 2711 2719 O
participation 70 83 2720 2733 O

patients 0 8 2734 2742 O
who 9 12 2743 2746 O
are 13 16 2747 2750 O
anticoagulated 17 31 2751 2765 B-treatment
for 32 35 2766 2769 O
atrial 36 42 2770 2776 B-chronic_disease
fibrillation 43 55 2777 2789 I-chronic_disease
or 56 58 2790 2792 O
other 59 64 2793 2798 O
conditions 65 75 2799 2809 O
may 76 79 2810 2813 O
participate 80 91 2814 2825 O
, 91 92 2825 2826 O
provided 93 101 2827 2835 O
they 102 106 2836 2840 O
are 107 110 2841 2844 O
on 111 113 2845 2847 O
stable 114 120 2848 2854 O
doses 121 126 2855 2860 O
of 127 129 2861 2863 O
anticoagulant 130 143 2864 2877 B-treatment
therapy 144 151 2878 2885 I-treatment

provided 0 8 2886 2894 O
they 9 13 2895 2899 O
are 14 17 2900 2903 O
on 18 20 2904 2906 O
stable 21 27 2907 2913 O
doses 28 33 2914 2919 O
of 34 36 2920 2922 O
anticoagulant 37 50 2923 2936 B-treatment
therapy 51 58 2937 2944 I-treatment

